Raytheon Beats Beryllium Class' Medical Monitoring Bid

Law360, New York (June 24, 2013, 7:35 PM EDT) -- A Massachusetts federal judge on Sunday rejected a bid by former Raytheon Co. workers to secure medical monitoring in a putative class action over exposure to hazardous beryllium, saying the plaintiffs could not prove they suffered subcellular damage.

U.S. District Judge Mark L. Wolf rejected arguments by five named plaintiffs, whose class action has been consolidated with another individual's suit, claiming that their exposure to beryllium dust and particles from Raytheon's Waltham, Mass., plant has led to an “increased risk” of subcellular change that warrants monitoring....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.